Sowell Financial Services LLC Takes Position in DaVita Inc. (NYSE:DVA)

Sowell Financial Services LLC acquired a new stake in shares of DaVita Inc. (NYSE:DVA - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,378 shares of the company's stock, valued at approximately $364,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DVA. UMB Bank n.a. raised its stake in DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after acquiring an additional 76 shares in the last quarter. Copia Wealth Management bought a new stake in DaVita during the 4th quarter valued at $30,000. SBI Securities Co. Ltd. bought a new stake in DaVita during the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC raised its stake in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after acquiring an additional 100 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan bought a new stake in DaVita during the 4th quarter valued at $55,000. Institutional investors and hedge funds own 90.12% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Truist Financial dropped their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Finally, Sanford C. Bernstein set a $184.00 target price on DaVita in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $164.50.

DaVita Stock Performance

Shares of DVA stock opened at $136.66 on Friday. DaVita Inc. has a 1-year low of $131.76 and a 1-year high of $179.60. The company has a current ratio of 1.25, a quick ratio of 1.20 and a debt-to-equity ratio of 23.18. The company has a market capitalization of $10.32 billion, a price-to-earnings ratio of 13.54, a P/E/G ratio of 0.94 and a beta of 1.11. The stock's fifty day simple moving average is $139.84 and its 200-day simple moving average is $150.19.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The business had revenue of $3.22 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the previous year, the company posted $2.26 earnings per share. DaVita's revenue for the quarter was up 5.0% compared to the same quarter last year. On average, sell-side analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.